Provided by Tiger Fintech (Singapore) Pte. Ltd.

CRISPR Therapeutics AG

52.17
+0.50000.97%
Pre-market: 52.00-0.1700-0.33%07:27 EDT
Volume:1.84M
Turnover:95.50M
Market Cap:4.51B
PE:-11.55
High:53.08
Open:52.36
Low:51.15
Close:51.67
Loading ...

RBC Lowers Price Target on CRISPR Therapeutics to $48 From $53, Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
12 Feb

CRISPR Therapeutics Ag : Leerink Partners Cuts Target Price to $65 From $67

THOMSON REUTERS
·
12 Feb

Crispr Therapeutics Is Maintained at Equal-Weight by Barclays

Dow Jones
·
12 Feb

Crispr Therapeutics price target raised to $56 from $55 at Barclays

TIPRANKS
·
12 Feb

Crispr Therapeutics AG (CRSP) Receives a Hold from Barclays

TIPRANKS
·
12 Feb

CRISPR Therapeutics Ag : RBC Cuts Target Price to $48 From $53

THOMSON REUTERS
·
12 Feb

Crispr Therapeutics AG’s Financial Challenges: Sell Rating Due to Casgevy Program Burden

TIPRANKS
·
12 Feb

CRISPR Therapeutics Ag : Truist Securities Raises Target Price to $120 From $100

THOMSON REUTERS
·
12 Feb

Crispr Therapeutics AG: Strategic Collaborations and Promising Pipeline Drive ‘Buy’ Rating

TIPRANKS
·
12 Feb

CRISPR Therapeutics Swings to Q4 Loss, Revenue Falls

MT Newswires Live
·
12 Feb

CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
12 Feb

CRISPR Therapeutics Q4 2024 GAAP EPS $(0.44) Beats $(1.13) Estimate, Sales $35.691M Beat $7.657M Estimate

Benzinga
·
12 Feb

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
12 Feb

BofA Securities Adjusts CRISPR Therapeutics Price Target to $86 From $85, Maintains Buy Rating

MT Newswires Live
·
11 Feb

Crispr Therapeutics AG (CRSP) Gets a Buy from Bank of America Securities

TIPRANKS
·
11 Feb

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

Zacks
·
11 Feb

Vertex forecasts upbeat 2025 revenue on cystic fibrosis treatments demand

Reuters
·
11 Feb

Truist Financial Reaffirms Their Buy Rating on Crispr Therapeutics AG (CRSP)

TIPRANKS
·
10 Feb

Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move

Motley Fool
·
10 Feb

CRISPR Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?

Zacks
·
07 Feb